Viewing Study NCT04428632


Ignite Creation Date: 2025-12-24 @ 9:32 PM
Ignite Modification Date: 2025-12-26 @ 7:28 PM
Study NCT ID: NCT04428632
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2020-12-11
First Post: 2020-06-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Oral Berotralstat Expanded Access Program
Sponsor: BioCryst Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module